🇺🇸 FDA
Pipeline program

Experimental: Hyperslim

CAAE: 86295325.3.1001.0229

Approved other active

Quick answer

Experimental: Hyperslim for Venous Thromboembolism (VTE) is a Approved program (other) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
Venous Thromboembolism (VTE)
Phase
Approved
Modality
other
Status
active

Clinical trials